# Syntara clinical trials: 31 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 31 trials with Syntara as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Syntara: 31 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/syntara

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 31
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 31, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 15, 2023 | NCT05904717 | Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder | Syntara | Phase 2 | Completed | REM Sleep Behavior Disorder | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05904717) |
| December 21, 2020 | NCT04676529 | Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary... | Syntara | Phase 1/2 | Completed | Myelofibrosis, Primary Myelofibrosis (PMF), Post- Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera... | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04676529) |
| December 3, 2019 | NCT04183517 | A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males | Syntara | Phase 1 | Completed | Pharmacokinetics | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04183517) |
| May 9, 2014 | NCT02134353 | A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects | Syntara | Phase 3 | Completed | Cystic Fibrosis | 423 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02134353) |
| June 21, 2013 | NCT01883531 | Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years | Syntara | Phase 2 | Completed | Cystic Fibrosis | 95 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01883531) |
| June 27, 2011 | NCT01380236 | A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma | Syntara | Phase 2 | Withdrawn | Asthma | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01380236) |
| July 8, 2010 | NCT01158898 | Efficacy of TPI ASM8 During a 14-Day Allergen Challenge | Syntara | Phase 2 | Completed | Asthma | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01158898) |
| February 26, 2010 | NCT01076491 | High Dose Inhaled Mannitol Study | Syntara | Phase 1/2 | Completed | Bronchiectasis | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01076491) |
| June 5, 2009 | NCT00914433 | Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy Volunteers | Syntara | Phase 1 | Withdrawn | Chronic Obstructive Pulmonary Disease | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00914433) |
| January 15, 2009 | NCT00822861 | Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma | Syntara | Phase 2 | Completed | Asthma | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00822861) |
| November 18, 2008 | NCT00792714 | Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients | Syntara | Phase 1 | Completed | Cystic Fibrosis | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00792714) |
| October 24, 2008 | NCT00779077 | Cystic Fibrosis (CF) Flow Rates Study | Syntara | Observational | Completed | Cystic Fibrosis | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00779077) |
| August 8, 2008 | NCT00730977 | A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device | Syntara | Phase 1/2 | Completed | Healthy, Bronchiectasis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00730977) |
| April 30, 2008 | NCT00669331 | Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis | Syntara | Phase 3 | Completed | Bronchiectasis | 485 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00669331) |
| April 11, 2008 | NCT00656565 | Inspiratory Flow and Volumes in Bronchiectatics | Syntara | Observational | Completed | Bronchiectasis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00656565) |
| March 7, 2008 | NCT00630812 | Long Term Administration of Inhaled Mannitol in Cystic Fibrosis | Syntara | Phase 3 | Completed | Cystic Fibrosis | 318 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00630812) |
| October 30, 2007 | NCT00550797 | Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma | Syntara | Phase 2 | Completed | Allergic Asthma | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00550797) |
| September 18, 2007 | NCT00531414 | Inspiratory Flow Using the Osmohaler | Syntara | Observational | Completed | Asthma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00531414) |
| June 7, 2007 | NCT00483743 | Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients | Syntara | Phase 2 | Completed | Copd Bronchitis | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00483743) |
| April 3, 2007 | NCT00455130 | A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis | Syntara | Phase 2 | Completed | Cystic Fibrosis | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00455130) |
| March 13, 2007 | NCT00446771 | A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal Subjects | Syntara | Phase 1 | Completed | Healthy Volunteers | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00446771) |
| March 13, 2007 | NCT00446680 | Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study | Syntara | Phase 3 | Completed | Cystic Fibrosis | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00446680) |
| March 13, 2007 | NCT00446667 | A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD | Syntara | Phase 1/2 | Withdrawn | COPD, Exacerbation | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00446667) |
| November 23, 2006 | NCT00402948 | Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients | Syntara | Phase 2 | Terminated | Asthma | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00402948) |
| May 19, 2006 | NCT00327808 | Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma | Syntara | Phase 2 | Completed | Asthma | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00327808) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 4 |
| Phase 1/2 | 5 |
| Phase 2 | 13 |
| Phase 3 | 6 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 27 |
| Withdrawn | 3 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Cystic Fibrosis | 9 |
| Asthma | 8 |
| Bronchiectasis | 5 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| REM Sleep Behavior Disorder | 1 |
| Primary Myelofibrosis | 1 |
| Lung Diseases, Obstructive | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Sign makers in the United States](https://specstream.ai/data/businesses/sign-makers/united-states)
- [Hot dog restaurants in the United States](https://specstream.ai/data/businesses/hot-dog-restaurants/united-states)
- [Banks in the United States](https://specstream.ai/data/businesses/banks/united-states)
- [Prosthetics providers in the United States](https://specstream.ai/data/businesses/prosthetics-providers/united-states)
- [Food and beverage distributors in the United States](https://specstream.ai/data/businesses/food-and-beverage-distributors/united-states)
- [Appliance repair companies in the United States](https://specstream.ai/data/businesses/appliance-repair-companies/united-states)
